Activity of a novel antimicrobial peptide against Pseudomonas aeruginosa biofilms

Is biofilm removal properly assessed? Comparison of different quantification methods in a 96-well plate system

(2016) Philipp Stiefel et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria

(2016) Giovanna Batoni et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Antimicrobial Peptides and Innate Lung Defenses

(2016) Pieter S. Hiemstra et al.   CHEST

Clinical potential of engineered cationic antimicrobial peptides against drug resistant biofilms

(2016) Jeffrey A. Melvin et al.   Expert Review of Anti-Infective Therapy

Engineered cationic antimicrobial peptide (eCAP) preventsPseudomonas aeruginosabiofilm growth on airway epithelial cells

(2016) Lauren P. Lashua et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Quantifying implant-associated biofilms: Comparison of microscopic, microbiologic and biochemical methods

(2016) Katharina Doll et al.   JOURNAL OF MICROBIOLOGICAL METHODS

Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections

(2016) Craig Winstanley et al.   TRENDS IN MICROBIOLOGY

Cystic fibrosis lung environment and Pseudomonas aeruginosa infection

(2016) Anjali Y. Bhagirath et al.   BMC Pulmonary Medicine

Visualizing the Effects of Sputum on Biofilm Development Using a Chambered Coverglass Model

(2016) Trevor Beaudoin et al.   Jove-Journal of Visualized Experiments

Pseudomonas aeruginosainfection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches

(2016) Helena Lund-Palau et al.   Expert Review of Respiratory Medicine

Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms

(2015) Sarah Kennedy et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of High-Dose Antimicrobials on Biofilm Growth of Achromobacter Species Isolated from Cystic Fibrosis Patients

(2015) Sean K. Tom et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The increasing threat of Pseudomonas aeruginosa high-risk clones

(2015) Antonio Oliver et al.   DRUG RESISTANCE UPDATES

Small colony variants ofPseudomonas aeruginosain chronic bacterial infection of the lung in cystic fibrosis

(2015) Thomas J Evans   Future Microbiology

Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients

(2015) Yvonne C.W. Yau et al.   Journal of Cystic Fibrosis

Pseudomonas aeruginosa Biofilm Infections: Community Structure, Antimicrobial Tolerance and Immune Response

(2015) Morten Rybtke et al.   JOURNAL OF MOLECULAR BIOLOGY

Engineered Cationic Antimicrobial Peptides To Overcome Multidrug Resistance by ESKAPE Pathogens

(2014) Berthony Deslouches et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Bovicin HC5 and nisin reduce Staphylococcus aureus adhesion to polystyrene and change the hydrophobicity profile and Gibbs free energy of adhesion

(2014) Natan de Jesus Pimentel-Filho et al.   INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY

pH modulates the activity and synergism of the airway surface liquid antimicrobials β-defensin-3 and LL-37

(2014) Mahmoud H. Abou Alaiwa et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Host defense peptides: front-line immunomodulators

(2014) Sarah C. Mansour et al.   TRENDS IN IMMUNOLOGY

Differential Binding of L- vs. D-isomers of Cationic Antimicrobial Peptides to the Biofilm Exopolysaccharide Alginate

(2013) Lois Yin et al.   PROTEIN AND PEPTIDE LETTERS

Inhibition of Bacterial Biofilm Formation and Swarming Motility by a Small Synthetic Cationic Peptide

(2012) César de la Fuente-Núñez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Roles of Hydrophobicity and Charge Distribution of Cationic Antimicrobial Peptides in Peptide-Membrane Interactions

(2012) Lois M. Yin et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Treatment of lung infection in patients with cystic fibrosis: Current and future strategies

(2012) Gerd Döring et al.   Journal of Cystic Fibrosis

Human β-defensin 3 inhibits antibiotic-resistant Staphylococcus biofilm formation

(2012) Chen Zhu et al.   JOURNAL OF SURGICAL RESEARCH

Cystic fibrosis: a mucosal immunodeficiency syndrome

(2012) Taylor Sitarik Cohen et al.   NATURE MEDICINE

PhoQ Mutations Promote Lipid A Modification and Polymyxin Resistance of Pseudomonas aeruginosa Found in Colistin-Treated Cystic Fibrosis Patients

(2011) Amanda K. Miller et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Use of Antimicrobial Peptides Against Microbial Biofilms: Advantages and Limits

(2011) Giovanna Batoni et al.   CURRENT MEDICINAL CHEMISTRY

Pseudomonas aeruginosabiofilms in cystic fibrosis

(2010) Niels Høiby et al.   Future Microbiology

Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial

(2010) Michael W. Konstan et al.   Journal of Cystic Fibrosis

Tobramycin inhalation powder for P. aeruginosa infection in cystic fibrosis: The EVOLVE trial

(2010) Michael W. Konstan et al.   PEDIATRIC PULMONOLOGY

Temporins and their synergism against Gram-negative bacteria and in lipopolysaccharide detoxification

(2009) Maria Luisa Mangoni et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

A combination of assays reveals biomass differences in biofilms formed byEscherichia colimutants

(2009) P. Sule et al.   LETTERS IN APPLIED MICROBIOLOGY

Bugs, Biofilms, and Resistance in Cystic Fibrosis

(2009) Jane C Davies   Respiratory Care

Membrane interactions of designed cationic antimicrobial peptides: The two thresholds

(2008) Evgenia Glukhov et al.   BIOPOLYMERS

Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation

(2008) J. Overhage et al.   INFECTION AND IMMUNITY